TMCnet News
Global Multiplexed Diagnostics Market Report 2024: Market Segments, Size, Trend and Market Projections for Upcoming YearsOur latest research report entitled Multiplexed Diagnostics Market (by method (very high density, high density, mid-density, low density and others), application(infectious diseases, oncology, cardiology, autoimmune diseases, allergic diseases and others) and end user(academic research, hospitals, diagnostic labs, pharma companies and others)) provides complete and deep insights into the market dynamics and growth of Multiplexed Diagnostics. Latest information on market risks, industry chain structure Multiplexed Diagnostics cost structure and opportunities are offered in this report. The past, present and forecast market information will lead to investment feasibility by studying the essential Multiplexed Diagnostics growth factors. The forecast Multiplexed Diagnostics Market information is based on the present market situation, growth opportunities, development factors, and opinion of the industry experts. An in-depth analysis of the company profiles, Multiplexed Diagnostics on a global and regional level and applications is conducted. The analysis of downstream buyers, sales channel, raw materials, and industry verticals is offered in this report. According to the report the global Multiplexed Diagnostics Market is projected to grow at a CAGR of 19.3% over the forecast period of 2018-2024. Ask for Sample Copy of Research Report with Table of Content @ https://www.infiniumglobalresearch.com/reports/sample-request/1345 The multiplexed diagnostic is used in biological samples that can detect multiple analytes in a single screening process. Multiplexed assays are used in the detection of cancer, functional biomolecules (DNA & RNA) and infectious disease. Moreover, multiplexed diagnostic assays have advantages, such as time efficiency and highly precise accuracy that can analyze defects and mutations in any functional biomolecules (DNA, RNA, and protein). Increase the incidence of chronic diseases is one of the major reasons that is driving the growth of the multiplexed diagnostics market. Multiplexed diagnostics helps in early diagnosis that minimizes the risk associated with chronic disease/infection and helps in proper treatment management. With increasing concern for early disease detection, the demand for the multiplexed diagnostic market will increase. Meanwhile, lack of trained professionals and less awareness regarding multiplexed diagnostic especially in developing and underdeveloped regions hinders the growth of the market. Increase awareness about the multiplexed diagnostic in untapped regions can create growth opportunities for the market in the near future North America accounts for 49.54% of market share in the multiplexed diagnostic market in 2017 and is expected to dominate throughout the forecast period, 2018-2024. The U.S drives the North America region on account of the rising prevalence of cardiac diseases and cancer and the availability of better healthcare infrastructure in this region. Asia Pacific region is expected to grow at the highest CAGR of 22.5% during the forecast period. Key Development- Mercodia had launched the AKURIO Islet hormone multiplex assay in collaboration with Quansys Bioscience in October 2017. This assay was designed to assess four different hormones in a pancreatic study that include glucagon, insulin, C-peptide, and proinsulin. AKURIO Islet hormone multiplex assay provides high data accuracy with reliable speed. Market Segmentation by Method, Application and End User The report on global Multiplexed diagnostics Market covers segments such as, method, application and end user. On the basis of method, the global multiplexed diagnostics Market is categorized into very high-density multiplexed assays, high density multiplexed assays, mid-density multiplexed assays, low density multiplexed assays, and others. On the basis of application, the global Multiplexed Diagnostics Market is categorized into infectious diseases, oncology, cardiology, autoimmune diseases, allergic diseases, and others. On the basis of the end user, the global Multiplexed Diagnostics Market is categorized into academic research, hospitals, diagnostic labs, pharma companies, and clinical research. Ask Discount for the latest research report @ https://www.infiniumglobalresearch.com/reports/request-discount/1345 Competitive Landscape The report provides profiles of the companies in the global Multiplexed diagnostics Market such as Agilent Technologies, Abbott Laboratories, Thermo Fisher Scientific, Inc., Siemens Healthineers, Bio-Rad Laboratories, Inc. and F. Hoffmann-La Roche Ltd, BioMérieux SA, Luminex Corporation, Illumina, Inc. and Others. Browse Detailed TOC, Description, and Companies Mentioned in Report @ https://www.infiniumglobalresearch.com/healthcare-medical-devices/global-multiplexed-diagnostics-market As a community-building service, TMCnet allows user submitted content which is not always proofed by TMCnet editors. If you feel this entry is of inferior quality or wish to report it for some reason, please forward the URL to "webedit [AT] tmcnet [DOT] com" with your comments. |